Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
synaptonemal complex protein 3 | 0.663 | 0.385 | 9.2E-05 |
|
disease | 0.630 | None | 1.000 | 3 | 0 | 2003 | 2005 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.500 | None | 1.000 | 14 | 0 | 1996 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.310 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
microRNA 506 | 0.585 | 0.615 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
deleted in azoospermia 1 | 0.705 | 0.385 |
|
disease | 0.200 | None | 0.895 | 19 | 0 | 1997 | 2018 | |||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.200 | None | 1.000 | 13 | 0 | 1991 | 2019 | ||||||||
|
BSCL2 lipid droplet biogenesis associated, seipin | 0.545 | 0.692 | 1.1E-09 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
golgi associated PDZ and coiled-coil motif containing | 0.561 | 0.654 | 8.4E-04 |
|
disease | 0.200 | None | 0 | 0 | |||||||||||
|
nuclear receptor subfamily 0 group B member 1 | 0.494 | 0.808 | 0.97 |
|
disease | 0.140 | None | 1.000 | 4 | 1 | 2005 | 2017 | ||||||||
|
ubiquitin specific peptidase 9 Y-linked | 0.743 | 0.269 | 5.7E-05 |
|
disease | 0.140 | None | 0.750 | 4 | 0 | 2000 | 2009 | ||||||||
|
nuclear receptor subfamily 5 group A member 1 | 0.479 | 0.731 | 0.99 |
|
disease | 0.130 | None | 1.000 | 3 | 0 | 2006 | 2015 | ||||||||
|
follicle stimulating hormone subunit beta | 0.631 | 0.577 | 0.34 |
|
disease | 0.130 | None | 0.667 | 3 | 0 | 2002 | 2019 | ||||||||
|
chromodomain Y-linked 1 | 0.805 | 0.231 |
|
disease | 0.130 | None | 1.000 | 3 | 0 | 2001 | 2015 | |||||||||
|
testis expressed 11 | 0.686 | 0.500 | 1.00 |
|
disease | 0.130 | None | 1.000 | 3 | 0 | 2015 | 2018 | ||||||||
|
sex determining region Y | 0.456 | 0.808 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2005 | 2018 | |||||||||
|
DEAD-box helicase 3 Y-linked | 0.722 | 0.269 | 0.96 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2000 | 2017 | ||||||||
|
meiosis specific with OB-fold | 0.769 | 0.192 | 3.0E-14 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
zinc finger MYND-type containing 15 | 0.861 | 0.038 | 5.3E-12 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2014 | 2020 | ||||||||
|
FA complementation group M | 0.543 | 0.731 | 2.4E-15 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2006 | 2006 | ||||||||
|
RNA binding motif protein Y-linked family 1 member A1 | 0.736 | 0.423 | 0.29 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
serine peptidase inhibitor Kazal type 2 | 0.890 | 0.077 | 7.0E-02 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
heat shock transcription factor Y-linked 1 | 0.821 | 0.077 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2013 | 2013 |